Abstract: Background and objective: Acute liver failure (ALF) is a type of disease with high mortality and rapid progression with no specific treatment methods currently available. Glucocorticoids exert beneficial clinical effects on therapy for ALF. However, the mechanism of this effect remains unclear and when to use glucocorticoids in patients with ALF is difficult to determine. The purpose of this study was to investigate the specific immunological mechanism of dexamethasone (Dex) on treatment of ALF induced by lipopolysaccharide (LPS)/D-galactosamine (D-GaIN) in mice. Methods: Male C57BL/6 mice were given LPS and D-GaIN by intraperitoneal injection to establish an animal model of ALF. Dex was administrated to these mice and its therapeutic effect was observed. Hematoxylin and eosin (H&E) staining was used to determine liver pathology. Multicolor flow cytometry, cytometric bead array (CBA) method, and next-generation sequencing were performed to detect changes of messenger RNA (mRNA) in immune cells, cytokines, and Kupffer cells, respectively. Results: A mouse model of ALF can be constructed successfully using LPS/D-GaIN, which causes a cytokine storm in early disease progression. Innate immune cells change markedly with progression of liver failure. Earlier use of Dex, at 0 h rather than 1 h, could significantly improve the progression of ALF induced by LPS/D-GaIN in mice. Numbers of innate immune cells, especially Kupffer cells and neutrophils, increased significantly in the Dex-treated group. In vivo experiments indicated that the therapeutic effect of Dex is exerted mainly via the glucocorticoid receptor (Gr). Sequencing of Kupffer cells revealed that Dex could increase mRNA transcription level of nuclear receptor subfamily 4 group A member 1 (Nr4a1), and that this effect disappeared after Gr inhibition. Conclusions: In LPS/D-GaIN-induced ALF mice, early administration of Dex improved ALF by increasing the numbers of innate immune cells, especially Kupffer cells and neutrophils. Gr-dependent Nr4a1 upregulation in Kupffer cells may be an important ALF effect regulated by Dex in this process.

早期使用地塞米松可通过糖皮质激素受体依赖的方式促进Kupffer中Nr4a1表达来改善小鼠急性肝衰竭

[1]Achuthan A, Aslam ASM, Nguyen Q, et al., 2018. Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity. Cell Death Dis, 9(3):267.

[2]Bao SX, Zheng JM, Li N, et al., 2017. Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clin Res Hepatol Gastroenterol, 41(2):147-155.

[3]Bernal W, Auzinger G, Dhawan A, et al., 2010. Acute liver failure. Lancet, 376(9736):190-201.

[4]Bonta PI, van Tiel CM, Vos M, et al., 2006. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol, 26(10):2288.

[5]Cain DW, Cidlowski JA, 2017. Immune regulation by glucocorticoids. Nat Rev Immunol, 17(4):233-247.

[6]Carpenter MD, Hu QW, Bond AM, et al., 2020. Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat Commun, 11(1):504.

[7]CMA (Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association), 2019. Guideline for diagnosis and treatment of liver failure. Chin J Hepatol, 27(1):18-26 (in Chinese).

[8]Fujiwara K, Yasui S, Yonemitsu Y, et al., 2014. Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure. Hepatol Res, 44(5):491-501.

[9]Gagliano T, Shah K, Gargani S, et al., 2020. PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression. J Clin Invest, 130(6):3188-3204.

[10]Garabuczi E, Sarang Z, Szondy Z, 2015. Glucocorticoids enhance prolonged clearance of apoptotic cells by upregulating liver X receptor, peroxisome proliferator- activated receptor-δ and UCP2. Biochim Biophys Acta, 1853(3):573-582.

[11]Hanna RN, Carlin LM, Hubbeling HG, et al., 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat Immunol, 12(8):778-785.

[12]Heideveld E, Hampton-O'Neil LA, Cross SJ, et al., 2018. Glucocorticoids induce differentiation of monocytes towards macrophages that share functional and phenotypical aspects with erythroblastic island macrophages. Haematologica, 103(3):395-405.

[13]Honda M, Surewaard BGJ, Watanabe M, et al., 2020. Perivascular localization of macrophages in the intestinal mucosa is regulated by Nr4a1 and the microbiome. Nat Commun, 11(1):1329.

[14]Joshi N, Kopec AK, Ray JL, et al., 2016. Fibrin deposition following bile duct injury limits fibrosis through an α_Mβ₂-dependent mechanism. Blood, 127(22):2751-2762.

[15]Kakisaka K, Kataoka K, Suzuki Y, et al., 2017. Appropriate timing to start and optimal response evaluation of high-dose corticosteroid therapy for patients with acute liver failure. J Gastroenterol, 52(8):977-985.

[16]Karkhanis J, Verna EC, Chang MS, et al., 2014. Steroid use in acute liver failure. Hepatology, 59(2):612-621.

[17]Leroux A, Ferrere G, Godie V, et al., 2012. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J Hepatol, 57(1):141-149.

[18]Lewis PS, Campana L, Aleksieva N, et al., 2020. Alternatively activated macrophages promote resolution of necrosis following acute liver injury. J Hepatol, 73(2):349-360.

[19]Lyu C, Shi QL, Qin Q, et al., 2019. A review of experimental liver injury models in mice. Chin J Comp Med, 29(1):107-113 (in Chinese).

[20]Panettieri RA, Schaafsma D, Amrani Y, et al., 2019. Non-genomic effects of glucocorticoids: an updated view. Trends Pharmacol Sci, 40(1):38-49.

[21]Possamai LA, Thursz MR, Wendon JA, et al., 2014. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol, 61(2):439-445.

[22]Robert O, Boujedidi H, Bigorgne A, et al., 2016. Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice. J Hepatol, 64(4):916-924.

[23]Scheving LA, Buchanan R, Krause MA, et al., 2007. Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes. Am J Physiol Gastrointest Liver Physiol, 293(3):G552-G559.

[24]Stravitz RT, Lee WM, 2019. Acute liver failure. Lancet, 394(10201):869-881.

[25]Tuckermann JP, Kleiman A, Moriggl R, et al., 2007. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest, 117(5):1381-1390.

[26]Valdez R, Cavinder CA, Varner DD, et al., 2019. Dexamethasone downregulates expression of several genes encoding orphan nuclear receptors that are important to steroidogenesis in stallion testes. J Biochem Mol Toxicol, 33(6):e22309.

[27]van de Garde MDB, Martinez FO, Melgert BN, et al., 2014. Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction. J Immunol, 192(3):1196-1208.

[28]Wang HJ, Xu X, Guan X, et al., 2020. Liposomal 9-aminoacridine for treatment of ischemic stroke: from drug discovery to drug delivery. Nano Lett, 20(3):1542-1551.

[29]Wang K, Wu ZB, Ye YN, et al., 2014. Plasma interleukin-10: a likely predictive marker for hepatitis B virus-related acute-on-chronic liver failure. Hepat Mon, 14(7):e19370.

[30]Yu WQ, Zhang SY, Fu SQ, et al., 2019. Dexamethasone protects the glycocalyx on the kidney microvascular endothelium during severe acute pancreatitis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(4):355-362.

[31]Zhao HL, Han QJ, Lu N, et al., 2018. HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation. Mol Immunol, 101:303-311.